Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like Bay Area's Global Blood Therapeutics Terminates Lung Disease Program October 22, 2017 Top 9 Biotech Giants to Work for in New Jersey July 5, 2017 Cutera Strengthens Leadership Team With Two Key Executive Appointments August 20, 2017
